Evidence map›Paper›PMID 34793295›Full record

ArticleMicrobial genomics2021

A species-wide genetic atlas of antimicrobial resistance in

Korakrit Imwattana, César Rodríguez, Thomas V Riley, Daniel R Knight

Abstract read
In one paragraph

Article in Microbial genomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Phylogenomic analysis of the collagen-like BclA proteins inApplied and environmental microbiology · 2026
    Article
  6. Article
  7. Resistome Profiling of a Large Collection ofInternational journal of molecular sciences · 2026
    Article
  8. Article
  9. Article
  10. Clostridioides difficile pathogenesis and control.Nature reviews. Microbiology · 2026
    Review
  11. Pangenome-GWAS analysis ofCanadian journal of microbiology · 2026
    Article
  12. Article
  13. Phenotypic and genotypic antimicrobial resistance profiles of clinical Clostridioides difficile isolates collected from private and public health settings in South Africa.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  14. Antimicrobial Resistance ofAntibiotics (Basel, Switzerland) · 2025
    Article
  15. Unique growth and morphology properties of Clade 5bioRxiv : the preprint server for biology · 2025
    Article
  16. Article
  17. Microbiology spectrum · 2025
    Article
  18. The fitness connection of antibiotic resistance.Frontiers in microbiology · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Korakrit ImwattanaSchool of Biomedical Sciences, University of Western Australia, Nedlands, Western Australia, Australia.
César RodríguezFacultad de Microbiología & Centro de Investigación en Enfermedades Tropicales (CIET), Universidad de Costa Rica, San José, Costa Rica.
Thomas V RileySchool of Biomedical Sciences, University of Western Australia, Nedlands, Western Australia, Australia.
Daniel R KnightSchool of Biomedical Sciences, University of Western Australia, Nedlands, Western Australia, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Clostridioides difficileClostridium InfectionsAnti-Bacterial AgentsClostridioidesDrug Resistance, BacterialHumansAnti-Bacterial Agentsantimicrobial resistanceClostridioides difficilegenomics

Identifiers

PMID34793295
PMCPMC8743556

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.